A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.

Enrico Celestino Nista; Marcello Candelli; Filippo Cremonini; Immacolata Alessia Cazzato; Maria Assunta Zocco; Francesco Franceschi; Giovanni Cammarota; Giovanni Battista Gasbarrini; Antonio Gasbarrini

A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.

Enrico Celestino Nista, Marcello Candelli, Filippo Cremonini, Immacolata Alessia Cazzato, Maria Assunta Zocco, Francesco Franceschi, Giovanni Cammarota, Giovanni Battista Gasbarrini, Antonio Gasbarrini

Risultato della ricerca: Contributo in rivista › Articolo in rivista

139 Citazioni (Scopus)

Abstract

The incidences of nausea, diarrhoea and epigastric pain in patients treated with B. clausii were significantly lower than in placebo group, in both PP and ITT analysis. Equally, intensity of nausea and diarrhoea in patients treated with B. clausii was significantly lower than in placebo group. There were no differences in adherence to treatment and H. pylori eradication rates between groups. Conclusion : In symptom-free, H. pylori-positive subjects B. clausii bacteriotherapy reduces the incidence of the most common side-effects related to anti-H. pylori antibiotic therapy compared with placebo

Lingua originale	English
pagine (da-a)	1181-1188
Numero di pagine	8
Rivista	ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Stato di pubblicazione	Pubblicato - 2004

Keywords

Bacillus clausii
HP

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{4f7d8b14e7ac49f994b133c1bf0ab13a,

title = "A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.",

abstract = "The incidences of nausea, diarrhoea and epigastric pain in patients treated with B. clausii were significantly lower than in placebo group, in both PP and ITT analysis. Equally, intensity of nausea and diarrhoea in patients treated with B. clausii was significantly lower than in placebo group. There were no differences in adherence to treatment and H. pylori eradication rates between groups. Conclusion : In symptom-free, H. pylori-positive subjects B. clausii bacteriotherapy reduces the incidence of the most common side-effects related to anti-H. pylori antibiotic therapy compared with placebo",

keywords = "Bacillus clausii, HP, Bacillus clausii, HP",

author = "Nista, {Enrico Celestino} and Marcello Candelli and Filippo Cremonini and Cazzato, {Immacolata Alessia} and Zocco, {Maria Assunta} and Francesco Franceschi and Giovanni Cammarota and Gasbarrini, {Giovanni Battista} and Antonio Gasbarrini",

year = "2004",

language = "English",

pages = "1181--1188",

journal = "ALIMENTARY PHARMACOLOGY & THERAPEUTICS",

issn = "0269-2813",

publisher = "Blackwell Science Limited:PO Box 88, Oxford OX2 0NE United Kingdom:011 44 1865 776868, 011 44 1865 206038, EMAIL: journals.cs@blacksci.co.uk, INTERNET: http://www.blackwell-science.com, Fax: 011 44 1865 721205",

}

TY - JOUR

T1 - A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.

AU - Nista, Enrico Celestino

AU - Candelli, Marcello

AU - Cremonini, Filippo

AU - Cazzato, Immacolata Alessia

AU - Zocco, Maria Assunta

AU - Franceschi, Francesco

AU - Cammarota, Giovanni

AU - Gasbarrini, Giovanni Battista

AU - Gasbarrini, Antonio

PY - 2004

Y1 - 2004

N2 - The incidences of nausea, diarrhoea and epigastric pain in patients treated with B. clausii were significantly lower than in placebo group, in both PP and ITT analysis. Equally, intensity of nausea and diarrhoea in patients treated with B. clausii was significantly lower than in placebo group. There were no differences in adherence to treatment and H. pylori eradication rates between groups. Conclusion : In symptom-free, H. pylori-positive subjects B. clausii bacteriotherapy reduces the incidence of the most common side-effects related to anti-H. pylori antibiotic therapy compared with placebo

AB - The incidences of nausea, diarrhoea and epigastric pain in patients treated with B. clausii were significantly lower than in placebo group, in both PP and ITT analysis. Equally, intensity of nausea and diarrhoea in patients treated with B. clausii was significantly lower than in placebo group. There were no differences in adherence to treatment and H. pylori eradication rates between groups. Conclusion : In symptom-free, H. pylori-positive subjects B. clausii bacteriotherapy reduces the incidence of the most common side-effects related to anti-H. pylori antibiotic therapy compared with placebo

KW - Bacillus clausii

KW - HP

KW - Bacillus clausii

KW - HP

UR - http://hdl.handle.net/10807/21036

M3 - Article

SN - 0269-2813

SP - 1181

EP - 1188

JO - ALIMENTARY PHARMACOLOGY & THERAPEUTICS

JF - ALIMENTARY PHARMACOLOGY & THERAPEUTICS

ER -

A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.

Abstract

Keywords

OSS delle Nazioni Unite

Altri file e collegamenti

Fingerprint

Cita questo